Transient Receptor Potential (TRP) Ion Channels Involved in Malignant Glioma Cell Death and Therapeutic Perspectives

Related Experiment Video

Updated: Oct 22, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

3.5K

Florence Lefranc1

  • 1Department of Neurosurgery, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

Frontiers in Cell and Developmental Biology
|August 30, 2021
PubMed

Insights

Malignant gliomas are aggressive brain tumors resistant to current therapies. Targeting Transient Receptor Potential (TRP) ion channels, like TRPV2 with cannabidiol, may offer new therapeutic strategies for glioma treatment.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Malignant gliomas are aggressive primary brain tumors with poor prognoses despite multimodal therapy.
  • Glioma stem cells contribute to tumor invasiveness and treatment resistance.
  • Ion channels, particularly Transient Receptor Potential (TRP) channels, play roles in cancer cell biology.

Purpose of the Study:

  • To review the role of TRP ion channels in malignant glioma cell death.
  • To identify potential therapeutic targets for combating malignant gliomas.
  • To explore the potential of targeting TRPV2 channels with cannabidiol.

Main Methods:

  • Literature review of scientific reports on TRP ion channels in malignant gliomas.
  • Analysis of TRP channel involvement in glioma cell death mechanisms.
  • Evaluation of potential therapeutic strategies targeting TRP channels.

Main Results:

  • TRP ion channels are implicated in calcium signaling and contribute to glioblastoma aggressiveness.
  • Several TRP channel subtypes are potentially involved in malignant glioma cell death.
  • Cannabidiol targeting the TRPV2 channel is identified as a potential therapeutic avenue.

Conclusions:

  • TRP ion channels represent promising therapeutic targets for malignant gliomas.
  • Targeting TRPV2 with cannabidiol may offer a novel strategy against glioblastoma.
  • Further research into TRP channel modulation is crucial for developing new glioma treatments.
Keywords:
TRP ion channelscannabidiolcell deathmalignant gliomatreatment

More Related Videos

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.6K
Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions07:39

Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions

Published on: November 17, 2021

3.7K

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.0K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
7.6K
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
13.2K
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K